Full List Of Stories
Wednesday preview: ECB, Great Portland Estates in the spotlight
Financial markets' focus in the middle of the week will be on the start of the European Central Bank Forum, with investors keen to hear the latest views from monetary authority's top officials on current economic conditions, although forecasts appear to be in a state of flux following the latest Covid-19 vaccine news.
Europe close: Stocks extend rally as EU lawmakers agree budget deal
European shares added to Monday's sharp gains after EU lawmakers agreed to the outlines of the bloc's next long-term budget.
Sector movers: Aerospace finds a bid, analysts divided on budget airlines and Rolls Royce
Aerospace and Defence names were again higher, although analysts' opinions were a little divided when it came to the likes of engineer Rolls Royce or budget airlines.
Peel Hunt downgrades Flutter Entertainment due to expected Covid-19 impact
Analysts at Peel Hunt downgraded their recommendation for shares of Flutter Entertainment following the shares' recent strong performance and after marking down its estimates for the sports betting gambling firm's earnings in 2021.
FTSE 250 risers: Capita still to see relief from Covid-19, SSP Group feeling it already
Capita shares were pacing gains on the second-tier index after it told shareholders that it still expected to comply with its debt covenants at year end 2020.
IAG and Easyjet will still need more liquidity in 2021, Morgan Stanley says
News of Pfizer and BioNTech's Covid-19 vaccine candidate's greater than 90% efficacy is positive for investor sentiment and reduces the probability of Morgan Stanley's 'bear case' ensuing, the broker said.
Go 'overweight' cyclicals, UK set to benefit the most from vaccine news, Credit Suisse says
Things are looking up for equities, especially the UK, in the wake of the reported 90% efficacy of Pfizer's Covid-19 vaccine candidate, said equity strategists at Credit Suisse.
FDA grants emergency use approval for Eli Lilly Covid-19 treatment
America's top health regulator has granted emergency use authorisation for Eli Lilly's Covid-19 antibody treatment.
UK to have 10m doses of Pfizer/BioNTech Covid-19 vaccine by end-2020, if approved
Britain will have 10m doses of the Covid-19 vaccine being developed by Pfizer and BioNTech by the end of 2020.